Study on Single-cell Regulons Atlas of Pancreatic Ductal Adenocarcinoma

CompletedOBSERVATIONAL
Enrollment

68

Participants

Timeline

Start Date

January 2, 2019

Primary Completion Date

February 25, 2020

Study Completion Date

April 21, 2024

Conditions
Pancreatic Ductal Adenocarcinoma (PDAC)Molecular Prognostic ModelRegulons
Trial Locations (1)

40030

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
lead

Tiejun Ying

OTHER

NCT06720454 - Study on Single-cell Regulons Atlas of Pancreatic Ductal Adenocarcinoma | Biotech Hunter | Biotech Hunter